Natural history of dilated cardiomyopathy: From asymptomatic left ventricular dysfunction to heart failure - A subgroup analysis from the Trieste Cardiomyopathy Registry

Journal of Cardiovascular Medicine

Volumn 10, Issue 9, 2009, Pages 699-705

  Aleksova, Aneta ^a   Sabbadini, Gastone ^a   Merlo, Marco ^a   Pinamonti, Bruno ^a   Barbati, Giulia ^a,b   Zecchin, Massimo ^a   Bussani, Rossana ^a   Silvestri, Furio ^a   Iorio, Anna M ^a   Stolfo, Davide ^a   Dal Ferro, Matteo ^a   Dragos, Andreea M ^a   Meringolo, Gennaro ^a   Pyxaras, Stelios ^a   Lo Giudice, Francesco ^a   Perkan, Andrea ^a   Di Lenarda, Andrea ^a   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Asymptomatic left ventricular dysfunction; Heart failure; Idiopathic dilated cardiomyopathy; Prognosis

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PROGNOSIS; QUALITY OF LIFE;

ADULT; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 68249150705     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832bba35     Document Type: Article

References (29)

1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93:841-842.
2. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-1402. (Pubitemid 35239711)
3. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81:1161-1172. (Pubitemid 20119612)
4. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 1999; 100:999-1008. (Pubitemid 29407182)
5. McMurray JV, McDonagh TA, Davie AP, Cleland JG, Francis CM, Morrison C. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998; 19:842-846.
6. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358:439-444. (Pubitemid 32769849)
7. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289:194-202.
8. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350:829-833. (Pubitemid 27404343)
9. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001; 38:2101-2113.
10. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 1992; 70:1180-1184.
11. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-691.
12. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327:669-677.
13. Redfield MM, Gersh BJ, Bailey KR, Rodeheffer RJ. Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74:737-739.
14. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18:619-624.
15. Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart muscle disease study group. J Am Coll Cardiol 1999; 34:181-190.
16. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989; 13:585-590. (Pubitemid 19073925)
17. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12:426-440.
18. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108:977-982. (Pubitemid 37048228)
19. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, et al. The American College of Cardiology/American Heart Association heart failure prevalence and prognostic significance of heart failure stages: application of staging criteria in the community. Circulation 2007; 115:1563-1570.
20. Goldberg LR, Jessup M. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation 2006; 113:2851-2860. (Pubitemid 44305298)
21. Frigerio M, Oliva F, Turazza FM, Bonow RO. Prevention and management of chronic heart failure in management of asymptomatic patients. Am J Cardiol 2003; 9A1:4F-9F. (Pubitemid 36555735)
22. Rodeheffer RJ. Epidemiology and screening of asymptomatic left ventricular dysfunction. J Card Fail 2002; 8:S253-S257. (Pubitemid 36083067)
23. Wang TJ, Levy D, Benjamin EJ, Vasan RS. The epidemiology of 'asymptomatic' left ventricular systolic dysfunction: implications for screening. Ann Intern Med 2003; 138:907-916.
24. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883. (Pubitemid 34984635)
25. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350:2151-2158. (Pubitemid 38637995)
26. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108:2883-2891. (Pubitemid 37517816)
27. Di Lenarda A, Pinamonti B, Mestroni L, Salvi A, Sabbadini G, Gregori D, et al. per il Gruppo di Studio sulle Malattie del Miocardio. How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste. Ital Heart J 2004; 5:253-264.
28. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
29. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549.